总时间（秒）：7.39
问答时间（秒）：7.19

Here is the analysis for some of the papers related to the given context:

1. Paper 1: AMP-activated protein kinase (AMPK) in Huntington's disease

```json
{
  "paper_title": "The role of AMP-activated protein kinase (AMPK) in Huntington's disease",
  "assay_type": "Cellular Phenotype Rescue Assay",
  "variant": "Huntingtin with expanded CAG repeats",
  "final_evidence_strength": {
    "type": "Pathogenic",
    "strength": "PS3_very_strong"
  },
  "overall_conclusion": "The use of Huntington's disease patient-derived cells and AMPK modulators demonstrate a clear therapeutic potential for treating Huntington's disease, suggesting the expanded CAG repeats in the huntingtin protein contribute to pathogenesis."
},
{
  "paper_title": "The role of autophagy in Huntington's disease",
  "assay_type": "Gene Expression Assay",
  "variant": "Huntingtin with expanded CAG repeats",
  "final_evidence_strength": {
    "type": "Pathogenic",
    "strength": "PS3_very_strong"
  },
  "overall_conclusion": "The study provides evidence that autophagy dysfunction is a key mechanism in Huntington's disease, and that genetic or pharmacological modulation of autophagy may hold therapeutic potential."
}
```

2. Paper 2: Protein misfolding cyclic aggregation (PMCA) in Alzheimer's disease

```json
{
  "paper_title": "The role of protein misfolding cyclic aggregation (PMCA) in Alzheimer's disease",
  "assay_type": "Cellular Phenotype Rescue Assay and Biochemical Assays",
  "variant": "Amyloid precursor protein (APP) with Swedish mutations",
  "final_evidence_strength": {
    "type": "Pathogenic",
    "strength": "PS3_very_strong"
  },
  "overall_conclusion": "The study suggests that the formation of PMCA contributes to the pathogenesis of Alzheimer's disease, and that inhibiting PMCA may have therapeutic potential."
}
```